MedTrace Logo

Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis

NCT00004938 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2006-06-09

No results posted yet for this study

Summary

OBJECTIVE:

I. Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral sporotrichosis.

Conditions

  • Sporotrichosis

Interventions

DRUG

fluconazole

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • William Dismukes · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-08-31
Completion
1996-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004938 on ClinicalTrials.gov